article thumbnail

IWD: Spotlight on women in life sciences

pharmaphorum

How did you get into life sciences? After a few years, I decided I wanted to move into the commercial side of the business, so I completed an MBA and went on to hold various positions in Corporate Business Development, Life Science and Healthcare. What has your career path been?

article thumbnail

SMi’s 5th Annual Pharmaceutical Microbiology East Coast Conference

pharmaphorum

Light is being shed on recent product recalls for mould contamination, and infection outbreaks serve as a reminder to pay more attention to these overlooked organisms, as well as considerations towards container closure integrity testing which is being increasingly deployed to block microbe movement. View the full agenda: [link].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Reliable Experts in Pharmacology Market: Pharma Consultants

Delveinsight

Especially in the field of Pharmaceutical & Life Sciences, a company’s all-around product life-cycle stages, which consist of planning, designing, constructing, product testing, and commissioning processes are provided by a Pharma Consultant. Different areas where Pharma Consultancies provide aid are: Business Development.

article thumbnail

Packaging Solutions for Pharmaceuticals & Medical Devices: Insights and Considerations

XTalks

Aaron Liss, Business Development at Curia, says that CCI testing (CCIT) is “essentially an elaborate term for leak testing performed in a very sensitive and quantitative fashion.” E&L testing is performed to substantiate that packaging materials will not contaminate the drug product over a product’s shelf life.

article thumbnail

Athersys Announces Three Appointments to Board of Directors

The Pharma Data

Prior to Celgene, she held leadership roles in marketing, sales and new business development from 2002 to 2011 at Johnson & Johnson. Mr. Shah is a seasoned executive, entrepreneur, and investor with more than 20 years of experience in building life science technology companies. Before that, Ms.